CSIMarket
 


X4 Pharmaceuticals Inc  (XFOR)
Other Ticker:  
 
 

XFOR's Net Cash Flow Growth by Quarter and Year

X4 Pharmaceuticals Inc's Net Cash Flow results by quarter and year




XFOR Net Cash Flow (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter December - -4.85 32.47 -18.77
III Quarter September - 43.02 -19.06 -20.17
II Quarter June - -68.52 -15.36 35.96
I Quarter March -38.98 41.88 5.39 -10.02
FY   -38.98 11.53 3.44 -13.00



XFOR Net Cash Flow first quarter 2024 Y/Y Growth Comment
X4 Pharmaceuticals Inc in the first quarter 2024 recorded net cash outflow of $ -38.98 millions.

According to the results reported in the first quarter 2024, X4 Pharmaceuticals Inc achieved the best Net Cash Flow growth in Biotechnology & Pharmaceuticals industry. While X4 Pharmaceuticals Inc' s Net Cash Flow no change of % ranks overall at the positon no. 32 in the first quarter 2024.




XFOR Net Cash Flow ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - 676.99 % - -
FY   - 235.17 % - -

Financial Statements
X4 Pharmaceuticals Inc's first quarter 2024 Net Cash Flow $ -38.98 millions XFOR's Income Statement
X4 Pharmaceuticals Inc's first quarter 2023 Net Cash Flow $ 41.88 millions Quarterly XFOR's Income Statement
New: More XFOR's historic Net Cash Flow Growth >>


XFOR Net Cash Flow (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - 28.98 % - -
FY (Year on Year)   - 235.17 % - -




Net Cash Flow first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #1
Healthcare Sector #7
Overall #32

Net Cash Flow Y/Y Growth Statistics
High Average Low
1559.19 % 351.56 % -273.65 %
(Dec 31 2022)   (Mar 31 2024)
Net Cash Flow first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #1
Healthcare Sector #7
Overall #32
Net Cash Flow Y/Y Growth Statistics
High Average Low
1559.19 % 351.56 % -273.65 %
(Dec 31 2022)   (Mar 31 2024)

Net Cash Flow by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

X4 Pharmaceuticals Inc's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


XFOR's I. Quarter Q/Q Net Cash Flow Comment
Current results of -38.98 millions by X4 Pharmaceuticals Inc appear even worse if you take a look at net cash outflow -4.85 millions in the fourth quarter.

Within Biotechnology & Pharmaceuticals industry X4 Pharmaceuticals Inc achieved highest sequential Net Cash Flow growth. While X4 Pharmaceuticals Inc's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


XFOR's I. Quarter Q/Q Net Cash Flow Comment
Recent accomplishment of -38.98 millions by X4 Pharmaceuticals Inc look even less good if you take a look at -4.85 millions in the previous quarter.

Within Biotechnology & Pharmaceuticals industry X4 Pharmaceuticals Inc achieved highest sequential Net Cash Flow growth. While X4 Pharmaceuticals Inc's Net Cash Flow growth quarter on quarter, overall rank is .


X4 Pharmaceuticals Inc's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Mar 31 2024)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Net Cash Flow 12 Months Ending $ -69.32 $ 11.54 $ 48.85 $ -13.23 $ 39.92
Y / Y Net Cash Flow Growth (TTM) - 236.52 % - - 1559.19 %
Year on Year Net Cash Flow Growth Overall Ranking # 25 # 25 # 45 # 19 # 0
Seqeuential Net Cash Flow Change (TTM) - -76.39 % - - 1064.53 %
Seq. Net Cash Flow Growth (TTM) Overall Ranking # 32 # 39 # 64 # 25 # 0




Cumulative Net Cash Flow growth Comment
X4 Pharmaceuticals Inc realized trailing twelve months net cash outflow of $ -69 millions, in the Mar 31 2024, compare to Net Cash Flow of $ 40 millions a year ago.

Among companies within the Healthcare sector 4 other companies have achieved higher trailing twelve month Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. 25.

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
1559.19 %
351.56 %
-273.65 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 1
Healthcare Sector # 5
Overall # 25

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
1559.19 %
351.56 %
-273.65 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 7
S&P 500 # 32
Cumulative Net Cash Flow growth Comment
X4 Pharmaceuticals Inc realized trailing twelve months net cash outflow of $ -69 millions, in the Mar 31 2024, compare to Net Cash Flow of $ 40 millions a year ago.

Among companies within the Healthcare sector 4 other companies have achieved higher trailing twelve month Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. 25.

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
1559.19 %
351.56 %
-273.65 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 1
Healthcare Sector # 5
Overall # 25

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
1559.19 %
351.56 %
-273.65 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 7
S&P 500 # 32




Other Net Cash Flow Growth
Biotechnology & Pharmaceuticals Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
XFOR's Net Cash Flow Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for XFOR's Competitors
Net Cash Flow Growth for X4 Pharmaceuticals Inc's Suppliers
Net Cash Flow Growth for XFOR's Customers

You may also want to know
XFOR's Annual Growth Rates XFOR's Profitability Ratios XFOR's Asset Turnover Ratio XFOR's Dividend Growth
XFOR's Roe XFOR's Valuation Ratios XFOR's Financial Strength Ratios XFOR's Dividend Payout Ratio
XFOR's Roa XFOR's Inventory Turnover Ratio XFOR's Growth Rates XFOR's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Mar 31 2024 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Mar 31 2024
Processa Pharmaceuticals Inc -0.56%$ -0.563 millions
Bio rad Laboratories Inc -1.92%$ -1.923 millions
Regulus Therapeutics Inc -4.29%$ -4.293 millions
Integrated Biopharma Inc-10.80%$ -10.803 millions
Becton Dickinson And Company-12.39%$ -12.387 millions
Blueprint Medicines Corporation-14.55%$ -14.547 millions
Bullfrog Ai Holdings Inc -18.20%$ -18.200 millions
Mineralys Therapeutics Inc -18.66%$ -18.659 millions
Edwards Lifesciences Corporation-21.97%$ -21.965 millions
Mirum Pharmaceuticals Inc -22.88%$ -22.875 millions
Anaptysbio inc-23.76%$ -23.755 millions
Escalon Medical Corp -24.50%$ -24.499 millions
Pliant Therapeutics Inc -25.83%$ -25.826 millions
Moonlake Immunotherapeutics-31.55%$ -31.551 millions
Ligand Pharmaceuticals Incorporated-37.93%$ -37.928 millions
Pavmed Inc -38.16%$ -38.161 millions
Jaguar Health Inc -41.54%$ -41.537 millions
Ani Pharmaceuticals Inc-48.52%$ -48.523 millions
Progyny Inc -49.88%$ -49.881 millions
Avadel Pharmaceuticals Plc-50.83%$ -50.829 millions
Harmony Biosciences Holdings inc -51.74%$ -51.738 millions
Voyager Therapeutics Inc -55.39%$ -55.387 millions
Airsculpt Technologies Inc -57.59%$ -57.588 millions
Sintx Technologies Inc -62.04%$ -62.044 millions
Ironwood Pharmaceuticals inc -65.07%$ -65.074 millions
Lucid Diagnostics Inc -65.55%$ -65.550 millions
Kiromic Biopharma Inc -66.50%$ -66.503 millions
Alimera Sciences Inc -71.13%$ -71.125 millions
Ibio inc -71.53%$ -71.531 millions
Vivos Therapeutics Inc -72.55%$ -72.555 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com